Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism

Thomas Farge, Estelle Saland, Fabienne de Toni, +40

Cancer Discovery

Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*

Sophie Georgin‐Lavialle, Benjamin Terrier, Alexis F. Guédon, +70

British Journal of Dermatology

Ruxolitinib is more effective than other JAK inhibitors to treat VEXAS syndrome: a retrospective multicenter study

Maël Heiblig, Marcela A. Ferrada, Matthew T. Koster, +22

Blood

Genetic hierarchy and temporal variegation in the clonal history of acute myeloid leukaemia

Pierre Hirsch, Yanyan Zhang, Ruoping Tang, +19

Nature Communications

Comparison between idiopathic and VEXAS-relapsing polychondritis: analysis of a French case series of 95 patients

Mohamed-Yacine Khitri, Alexis F. Guédon, Sophie Georgin‐Lavialle, +25

RMD Open

Isocitrate dehydrogenase 1 mutations prime the all-trans retinoic acid myeloid differentiation pathway in acute myeloid leukemia

Héléna Boutzen, Estelle Saland, Clément Larrue, +24

The Journal of Experimental Medicine

ATP Binding Cassette transporters associated with chemoresistance: transcriptional profiling in extreme cohorts and their prognostic impact in a cohort of 281 acute myeloid leukemia patients

Christophe Marzac, Efraí­n Garrido, R. Tang, +9

Haematologica

Mediastinal gray zone lymphoma: clinico-pathological characteristics and outcomes of 99 patients from the Lymphoma Study Association

Clémentine Sarkozy, Thierry Jo Molina, Hervé Ghesquières, +17

Haematologica

Female Genital Chronic Graft-Versus-Host Disease

Pierre Hirsch, Mathieu Leclerc, M. Rybojad, +7

Transplantation

High Id1 expression is associated with poor prognosis in 237 patients with acute myeloid leukemia

Ruoping Tang, Pierre Hirsch, Fanny Fava, +6

Blood